{
    "nct_id": "NCT04508179",
    "official_title": "A Phase 1, Placebo-controlled, Within-Cohort Randomized, Double-blind, Single and Multiple Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of 7HP349 in Normal Healthy Male Subjects",
    "inclusion_criteria": "* Healthy males between the ages of 18 and 45 years, inclusive\n* Normal clinical chemistry, hepatic function, hematology, thyroid function\n* Body mass index (BMI) of 19 to 30 kg/m2 inclusive and body weight not less than 60 kg\n* Agree to refrain from consuming products containing grapefruit, pomelo, star fruit or Seville oranges for at least 7 days before the first dose of study drug until the final discharge evaluation\n* Positive immune status as defined in serum as measles, mumps, varicella-zoster viruses (VZR); Antibody Index (AI) ≥ 1.1, and positive Rubella: AI ≥ 1.0\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 45 Years",
    "exclusion_criteria": "* Clinically significant history of disorders, infections or drug hypersensitivity as determined by the Investigator\n* History of malignancy, with the exception of cured basal cell or squamous cell carcinoma of the skin\n* Positive blood screen for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), or hepatitis C antibody\n* Current treatment or treatment within 30 days with another investigational medication",
    "miscellaneous_criteria": ""
}